期刊
FREE RADICAL BIOLOGY AND MEDICINE
卷 71, 期 -, 页码 390-401出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2014.03.003
关键词
Mitochondria-targeted antioxidants; MitoQ; Alzheimer disease; Caenorhabditis elegans; beta-Amyloid peptides; Oxidative stress; Lifespan; Healthspan; Cytochrome c oxidase; Complex IV; Cardiolipin; Electron transport chain; Free radicals
资金
- Ministry of Education Singapore [MOE2010-T2-2-048]
beta-Amyloid (A beta)-induced toxicity and oxidative stress have been postulated to play critical roles in the pathogenic mechanism of Alzheimer disease (AD). We investigated the in vivo ability of a mitochondria-targeted antioxidant, MitoQ to protect against A beta-induced toxicity and oxidative stress in a Caenorhabditis elegans model overexpressing human A beta. Impairment of electron transport chain (ETC) enzymatic activity and mitochondrial dysfunction are early features of AD. We show that MitoQ extends lifespan, delays A beta-induced paralysis, ameliorates depletion of the mitochondrial lipid cardiolipin, and protects complexes IV and I of the ETC. Despite its protective effects on lifespan, healthspan, and ETC function, we find that MitoQ does not reduce DCFDA fluorescence, protein carbonyl levels or modulate steadystate ATP levels or oxygen consumption rate. Moreover, MitoQ does not attenuate mitochondrial DNA (mtDNA) oxidative damage. In agreement with its design, the protective effects of MitoQ appear to be targeted specifically to the mitochondrial membrane and our findings suggest that MitoQ may have therapeutic potential for A beta- and oxidative stress-associated neurodegenerative disorders, particularly AD. (C) 2014 The Authors. Published by Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据